Markus Schade - Concepedia

Author

Markus Schade

AstraZeneca (United Kingdom)ORCID

Also Known As

M Schade, M. Schade, Markus Schade, Schade, Markus, Schade, Martin

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)Massachusetts Institute of Technology Leibniz-Forschungsinstitut für Molekulare Pharmakologie AstraZeneca (Sweden)AstraZeneca (United States)

About

Markus Schade is an author at AstraZeneca (United Kingdom) specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	380
2	Natural Sciences	7	7	459
3	Biochemistry	5	5	408
4	Engineering	4	4	53
5	Applied Physics	3	3	43

Markus Schade

Publications

Citations

H-Index

Page 1

	Year	Citations
Design and Structure of Stapled Peptides Binding to Estrogen Receptors Chris Phillips, Lee R. Roberts, Markus Schade, Journal of the American Chemical Society BiochemistryStapled PeptidesProtein FoldingStapled Peptides BindingReceptor Signaling	2011	248
Structure-function analysis of the Z-DNA-binding domain Zalpha of dsRNA adenosine deaminase type I reveals similarity to the (alpha +beta ) family of helix-turn-helix proteins Markus Schade The EMBO Journal BiochemistryStructural BioinformaticsNatural SciencesRna Structure PredictionOligonucleotide	1999	99
The solution structure of the Zα domain of the human RNA editing enzyme ADAR1 reveals a prepositioned binding surface for Z-DNA Markus Schade, Christopher J. Turner, Ronald Kühne, Proceedings of the National Academy of Sciences	1999	93
High-resolution investigations of ripple structures formed by femtosecond laser irradiation of silicon Markus Schade, Olga Varlamova, J. Reif, Analytical and Bioanalytical Chemistry	2009	70
Antigen 85C Inhibition Restricts Mycobacterium tuberculosis Growth through Disruption of Cord Factor Biosynthesis Thulasi Warrier, Marielle Tropis, Jim Werngren, Antimicrobial Agents and Chemotherapy	2012	63
The solution structure of the N-terminal domain of E3L shows a tyrosine conformation that may explain its reduced affinity to Z-DNA <i>in vitro</i> Jan D. Kahmann, Diana A. Wecking, Vera Pütter, Proceedings of the National Academy of Sciences	2004	51
Structural and Physicochemical Features of Oral PROTACs Markus Schade, James S. Scott, Thomas G. Hayhow, Journal of Medicinal Chemistry	2024	44
In-Cell Quantification of Drugs by Magic-Angle Spinning Dynamic Nuclear Polarization NMR Andrea Bertarello, Pierrick Berruyer, Markus Artelsmair, Journal of the American Chemical Society	2022	39
Discovery of Low‐Molecular‐Weight Ligands for the AF6 PDZ Domain Mangesh Joshi, Carolyn Vargas, Prisca Boisguérin, Angewandte Chemie International Edition	2006	37
Novel Small Molecule Inhibitors of MDR <i>Mycobacterium tuberculosis</i> by NMR Fragment Screening of Antigen 85C Christoph Scheich, Vera Puetter, Markus Schade Journal of Medicinal Chemistry Drug TargetAntigen 85CTuberculosis PreventionMolecular BiologyNovel Antibiotics	2010	37

Page 1